NASDAQ
$3.05
$3.05

Overview

Price performance
Low
$3.00
High
$3.23
Market closed. Last updated: Nov 4, 2026, 9:00 PM UTC
$
3.05
0.00 (0.00%)
Average, 50 days
$4.48
$7.31
Open
$3.13
Previous close
$3.05
52-week high
$13.15
Jan 12, 2026 (10 months ago)
52-week low
$2.91
Nov 2, 2026 (4 days ago)
4.81%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
303.31M
Volume
2 494 294
Total Return (3M)
-42.67%
Total Return (1Y)
-64.98%
3.59
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
About
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.